Crohn's disease inflammatory bowel disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Clinically suspected inflammatory bowel disease Scheduled to undergo endoscopy Scheduled to undergo MRI Written Informed patients (>12 years of age) and parental consent
Exclusion criteria
Exclusion criteria: Age 18 years General contraindications for MRI (such as pregnancy, claustrophobia, renal insufficiency) or endoscopy Lack of written informed consent Inability to perform a 20 second breath hold Inability to drink 800 ml of the oral contrast agent (Sorbitol).
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| The secondary study parameters will be the comparison of DCE-MRI with histopathological biopsies and Pedriatric Crohn*s Disease Activity Index en Pediatric Ulcerative Colitis Activity Index scores for grading disease activity in IBD patients. | — |
Primary
| Measure | Time frame |
|---|---|
| The main study parameter will be the accuracy of diagnosing CD or UC with dynamic contrast enhanced MR enterography and colonography as compared to upper and lower tract endoscopy and abdominal ultrasound. | — |
Countries
Netherlands